Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma. Read more about Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma.
Do flame retardant chemicals increase the risk for thyroid dysregulation and cancer? Read more about Do flame retardant chemicals increase the risk for thyroid dysregulation and cancer?
Single-cell approaches for molecular classification of endocrine tumors. Read more about Single-cell approaches for molecular classification of endocrine tumors.
New targeted therapies and other advances in the management of anaplastic thyroid cancer. Read more about New targeted therapies and other advances in the management of anaplastic thyroid cancer.
Aggressive variants of papillary thyroid cancer. Read more about Aggressive variants of papillary thyroid cancer.
Vandetanib and the management of advanced medullary thyroid cancer. Read more about Vandetanib and the management of advanced medullary thyroid cancer.
Malignancy in the HIV-infected patients undergoing liver and kidney transplantation. Read more about Malignancy in the HIV-infected patients undergoing liver and kidney transplantation.
Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings. Read more about Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings.
The molecular diagnosis and management of thyroid neoplasms. Read more about The molecular diagnosis and management of thyroid neoplasms.
Postoperative calcium supplementation in patients undergoing thyroidectomy. Read more about Postoperative calcium supplementation in patients undergoing thyroidectomy.
